Information  X 
Enter a valid email address

Sunplus Technology (SUPD)

  Print   

Friday 13 November, 2020

Sunplus Technology

3rd Quarter Results

RNS Number : 2472F
Sunplus Technology Co Limited
13 November 2020
 

Su nplus Technology Company Limited

Consolidated Balance Sheets

Ended September 30, 2020*

(In Thousands of New Taiwan Dollars)

 

Assets

Amount

Liabilities & Shareholders Equity

Amount

Cash & Equivalent

3,284,620

Current Liabilities

1,670,464

Financial assets at fair value through profit or loss-current 

582,232

Non-Current Liabilities

778,629

Accounts & Notes receivable

1,219,582

Total Liabilities

2,449,093

Other Receivable

23,956

Equity attributable to owners of the parent


Inventories

935,227

Capital stock

5,919,949

Other current assets

237,701

Shares to be issued


Total Current Assets

6,283,318

Capital surplus

496,874



Appropriated as legal reserve

1,712,390

Financial assets at fair value through profit or loss - non-current

1,077,619

Appropriated as special reserve

276,189

Financial assets at fair value through other comprehensive income - non-current

183,124

Unappropriated earnings (deficit)

131,141

Investments accounted for using the equity method

712,170

Others

(310,584)

Property, plant and equipment

1,972,524

Treasury Stock

(63,401)

Right-of-use asset

231,797

Total equity attributable to owners of the parent

8,162,558

Investment properties

1,008,415



Intangible Assets-Net

321,675

Non-Controlling Interests

1,490,113

Deferred tax assets

30,084

Total Shareholders¡ Equity

9,652,671

Net defined benefit asset , non-current

1,163



Other Non-Current Assets

279,875



Total Non-Current Assets

5,818,446



Total Assets

  12,101,764

Total Liabilities & Shareholders' Equity

12,101,764



 

Sunplus Technology Company Limited

Consolidated Statements of Income

From January 1 to September 30, 2020 and 2019

(In Thousands of New Taiwan Dollars, Except Earnings per share)  

Unit: NT$K, Except EPS

20 20

201 9

YoY

Net sales

4,586,008

4,188,646

9.49

Cost

2,489,269

2,379,656

4.61

Gross Profit

2,096,739

1,808,990

15.91

  Marketing Expense

255,797

209,424

22.14

  General& Administrative Expense

352,728

372,162

(5.22)

R&D Expenses

1,174,949

1,122,046

4.71

Expected credit (gain) loss

(51)

183

(127.87)

Other operating income ( Expense )

116

116

-

Total operating income (expense )

313,432

105,291

197.68

Total non-operating income (expense )

126,935

97,498

30.19

Income(loss) before income tax from continued operating units

440,367

202,789

117.16

Income tax expense

112,439

52,755

113.13

Consolidated Net Income(loss)

327,928

150,034

118.57

Consolidated Net Income(loss)
Attributable To Shareholders of the parent

132,496

14,717

800.29

Consolidated Earnings Per Share NT$ Attributable To Shareholders of the parent*

$0.23

$0.03


* Based on outstanding 588,434,923 shares on 2020/09/30



Sunplus Technology Company Limited

Consolidated Cash Flow Summary

From January 1 to September 30, 2020 and 2019

(In Thousand New Taiwan Dollars)

 

ITEM

2020

2019

Cash Flow in (out) from operating

302,837

252,266

Cash Flow in (out) from Investing

(21,274)

(20,046)

Cash Flow in (out) from Financing

(9,969)

(606,088)

Impact from Fx Change

(7,602)

2,268

Net Increase (Decrease) in Cash & Cash Equivalents

263,992

(371,600)

Cash & Cash Equivalents, Beginning of Period

3,020,628

3,235,721

Cash & Cash Equivalents, End of Period

3,284,620

2,864,121

 

 


Spokesman

Wayne Shen

Tel: +886-3-5786005 ext. 2350

E-mail: [email protected]

 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTFZMMMNFZGGZG

a d v e r t i s e m e n t